|
1
|
Farina P, Lombardi G, Bergo E, Roma A and
Zagonel V: Treatment of malignant gliomas in elderly patients: A
concise overview of the literature. Biomed Res Int.
2014:7342812014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wen PY and Huse JT: 2016 World Health
Organization classification of central nervous system tumors.
Continuum (Minneap Minn). 23:1531–1547. 2017.PubMed/NCBI
|
|
3
|
Omuro A and DeAngelis LM: Glioblastoma and
other malignant gliomas: A clinical review. JAMA. 310:1842–1850.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gusyatiner O and Hegi ME: Glioma
epigenetics: From subclassification to novel treatment options.
Semin Cancer Biol. 51:50–58. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Salzman J: Circular RNA expression: Its
potential regulation and function. Trends Genet. 32:309–316. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Eger N, Schoppe L, Schuster S, Laufs U and
Boeckel JN: Circular RNA Splicing. Adv Exp Med Biol. 1087:41–52.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sanger HL, Klotz G, Riesner D, Gross HJ
and Kleinschmidt AK: Viroids are single-stranded covalently closed
circular RNA molecules existing as highly base-paired rod-like
structures. Proc Natl Acad Sci USA. 73:3852–3856. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Han B, Chao J and Yao H: Circular RNA and
its mechanisms in disease: From the bench to the clinic. Pharmacol
Ther. 187:31–44. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Belousova EA, Filipenko ML and Kushlinskii
NE: Circular RNA: New regulatory molecules. Bull Exp Biol Med.
164:803–815. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen B and Huang S: Circular RNA: An
emerging non-coding RNA as a regulator and biomarker in cancer.
Cancer Lett. 418:41–50. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu Y, Yao Y, Zhong X, Leng K, Qin W, Qu L,
Cui Y and Jiang X: Downregulated circular RNA hsa_circ_0001649
regulates proliferation, migration and invasion in
cholangiocarcinoma cells. Biochem Biophys Res Commun. 496:455–461.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang R, Zhang S, Chen X, Li N, Li J, Jia
R, Pan Y and Liang H: EIF4A3-induced circular RNA MMP9 (circMMP9)
acts as a sponge of miR-124 and promotes glioblastoma multiforme
cell tumorigenesis. Mol Cancer. 17:1662018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu H, Wang Y, Zhang T, Zhang C, Liu Y, Li
G, Zhou D and Lu S: Association of LncRNA-GACAT3 with MRI features
of breast cancer and its molecular mechanism. J BUON. 24:2377–2384.
2019.PubMed/NCBI
|
|
14
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mannhalter C, Koizar D and Mitterbauer G:
Evaluation of RNA isolation methods and reference genes for RT-PCR
analyses of rare target RNA. Clin Chem Lab Med. 38:171–177. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dudekula DB, Panda AC, Grammatikakis I, De
S, Abdelmohsen K and Gorospe M: CircInteractome: A web tool for
exploring circular RNAs and their interacting proteins and
microRNAs. RNA Biol. 13:34–42. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42:D92–D97. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu Y, Yao Y, Leng K, Ji D, Qu L, Liu Y and
Cui Y: Increased expression of circular RNA circ_0005230 indicates
dismal prognosis in breast cancer and regulates cell proliferation
and invasion via miR-618/CBX8 signal pathway. Cell Physiol Biochem.
51:1710–1722. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu Y, Yao Y, Gao P and Cui Y: Upregulated
circular RNA circ_0030235 predicts unfavorable prognosis in
pancreatic ductal adenocarcinoma and facilitates cell progression
by sponging miR-1253 and miR-1294. Biochem Biophys Res Commun.
509:138–142. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qi X, Zhang DH, Wu N, Xiao JH, Wang X and
Ma W: ceRNA in cancer: Possible functions and clinical
implications. J Med Genet. 52:710–718. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang Q, Shi L, Shi K, Yuan B, Cao G, Kong
C, Fu J, Man Z, Li X, Zhang X, et al: CircCSPP1 functions as a
ceRNA to promote colorectal carcinoma cell EMT and liver metastasis
by upregulating COL1A1. Front Oncol. 10:8502020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bai N, Peng E, Qiu X, Lyu N, Zhang Z, Tao
Y, Li X and Wang Z: circFBLIM1 act as a ceRNA to promote
hepatocellular cancer progression by sponging miR-346. J Exp Clin
Cancer Res. 37:1722018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhu W, Qian J, Ma L, Ma P, Yang F and Shu
Y: MiR-346 suppresses cell proliferation through SMYD3 dependent
approach in hepatocellular carcinoma. Oncotarget. 8:65218–65229.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li Y, Xu J, Zhang J, Zhang J, Zhang J and
Lu X: MicroRNA-346 inhibits the growth of glioma by directly
targeting NFIB. Cancer Cell Int. 19:2942019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hultgren EM, Patrick ME, Evans RL, Stoos
CT and Egland KA: SUSD2 promotes tumor-associated macrophage
recruitment by increasing levels of MCP-1 in breast cancer. PLoS
One. 12:e01770892017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu Y, Miao C, Jin C, Qiu C, Li Y, Sun X,
Gao M, Lu N and Kong B: SUSD2 promotes cancer metastasis and
confers cisplatin resistance in high grade serous ovarian cancer.
Exp Cell Res. 363:160–170. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cheng Y, Wang X, Wang P, Li T, Hu F, Liu
Q, Yang F, Wang J, Xu T and Han W: SUSD2 is frequently
downregulated and functions as a tumor suppressor in RCC and lung
cancer. Tumour Biol. 37:9919–9930. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sheets JN, Patrick ME and Egland KA: SUSD2
expression correlates with decreased metastasis and increased
survival in a high-grade serous ovarian cancer xenograft murine
model. Oncotarget. 11:2290–2301. 2020. View Article : Google Scholar : PubMed/NCBI
|
